William E Karle1, Samuel N Helman1, Amy Cooper2, Yuan Zhang3, Michael J Pitman2. 1. 1 Department of Otolaryngology-Head and Neck Surgery, New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. 2. 2 The Voice and Swallowing Institute, Department of Otolaryngology-Head and Neck Surgery, Columbia University Medical Center, New York Presbyterian Hospital, New York, New York, USA. 3. 3 Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York, USA.
Abstract
OBJECTIVE: Sulcus vocalis and vocal fold scar involve derangement of the superficial lamina propria of the vocal fold, which results in significant dysphonia. Many options exist for treatment, most of which have unsatisfactory and unpredictable outcomes. Autologous transplantation of temporalis fascia into the vocal fold (ATFV) has the potential to be a better treatment option, but long-term outcomes have not been well studied. METHODS: Retrospective chart review and patient survey. Twenty-one patients diagnosed with vocal fold scar or sulcus vocalis and treated with ATFV with at least 1-year follow-up were included. Voice Handicap Index 10 (VHI-10) questionnaires were collected preoperatively and 6 months postoperatively. Patients were reached at the time of the study to complete another VHI-10 and a Likert scale survey. RESULTS: The mean decrease in VHI-10 scores between preoperation and 6 months postoperation was 8.35 ( P < .001). From preoperation to the time of the study (average 44 months; range, 12-72 months), the VHI decreased 13.53 ( P < .001). Eighty-eight percent of patients reported they would recommend this surgery to others with the same diagnosis. Only 1 minor self-limited complication occurred. CONCLUSION: Autologous transplantation of temporalis fascia into the vocal fold for the treatment of vocal fold scar and sulcus vocalis is a safe surgery with good long-term outcomes and high patient satisfaction.
OBJECTIVE: Sulcus vocalis and vocal fold scar involve derangement of the superficial lamina propria of the vocal fold, which results in significant dysphonia. Many options exist for treatment, most of which have unsatisfactory and unpredictable outcomes. Autologous transplantation of temporalis fascia into the vocal fold (ATFV) has the potential to be a better treatment option, but long-term outcomes have not been well studied. METHODS: Retrospective chart review and patient survey. Twenty-one patients diagnosed with vocal fold scar or sulcus vocalis and treated with ATFV with at least 1-year follow-up were included. Voice Handicap Index 10 (VHI-10) questionnaires were collected preoperatively and 6 months postoperatively. Patients were reached at the time of the study to complete another VHI-10 and a Likert scale survey. RESULTS: The mean decrease in VHI-10 scores between preoperation and 6 months postoperation was 8.35 ( P < .001). From preoperation to the time of the study (average 44 months; range, 12-72 months), the VHI decreased 13.53 ( P < .001). Eighty-eight percent of patients reported they would recommend this surgery to others with the same diagnosis. Only 1 minor self-limited complication occurred. CONCLUSION: Autologous transplantation of temporalis fascia into the vocal fold for the treatment of vocal fold scar and sulcus vocalis is a safe surgery with good long-term outcomes and high patient satisfaction.
Authors: Yue Ma; Jennifer Long; Milan R Amin; Ryan C Branski; Edward J Damrose; Chih-Kwang Sung; Stratos Achlatis; Ann Kearney; Dinesh K Chhetri Journal: Laryngoscope Date: 2019-12-05 Impact factor: 3.325
Authors: Emke M J M van den Broek; Bas J Heijnen; Martine Hendriksma; Vivienne A H van de Kamp-Lam; Antonius P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren Journal: Eur Arch Otorhinolaryngol Date: 2019-05-27 Impact factor: 2.503
Authors: Emke M J M van den Broek; Bas J Heijnen; Martine Hendriksma; Vivienne A H van de Kamp-Lam; Thijs O Verhagen; Antonius P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren Journal: Eur Arch Otorhinolaryngol Date: 2020-04-02 Impact factor: 2.503